[Pain in the lower part of the spine in spinal osteochondrosis: experience in using chondroprotective drugs].
OBJECTIVE
To assess the response to chondroitin sulfate (structum) in low back pain (LBP) due to spinal osteochondrosis.


METHODS
30 patients (mean age 51.4 years) with a definite primary LBP took structum in a dose 1 g/day for 24 weeks. The diagnosis was made according to WHO recommendations (2000). The response was assessed with uniform international questionnaires and visual analogue scale.


RESULTS
The treatment reduced pain syndrome and improved spinal function in 73.3% patients with LBP studied.


CONCLUSIONS
It would be valid to include long-acting chondroprotective drugs in the program of LBP in spinal osteochondrosis.
D000328:Adult; D000368:Aged; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010007:Osteochondritis / Q000188:drug therapy / Q000503:physiopathology*; D010146:Pain / Q000188:drug therapy / Q000503:physiopathology*; D013122:Spinal Diseases / Q000188:drug therapy / Q000503:physiopathology*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D002809:Chondroitin Sulfates
Voli v nizhneĭ chasti spiny pri osteokhondroze pozvonochnika: opyt primeneniia khondroprotektivnogo preparata.